Clinical trials
Completed Hypertension trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 4 |
| Pontificia Universidad Catolica de Chile | 3 |
| Sanofi | 3 |
| Cristian Alvarez | 2 |
| University of British Columbia | 2 |
| Boehringer Ingelheim | 1 |
| CSL Behring | 1 |
| Columbia University | 1 |
| Daiichi Sankyo | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 26 |
| Cardiovascular Diseases | 6 |
| Stroke | 4 |
| Essential Hypertension | 3 |
| Vascular Diseases | 3 |
| Hypotension | 2 |
| Metabolic Diseases | 2 |
| Peripheral Vascular Diseases | 2 |
| Acute Coronary Syndrome | 1 |
| Agnosia | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.